Chris Buyse - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Chris Buyse’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Regenerative Medicine,
- Genetics,
- Wellness,
- Tissue Engineering,
- Healthcare Innovation,
- Life Science,
- Portfolio Management,
- Diabetes,
- Finance,
- Biotechnology,
- Medical Devices,
- Genomics,
- Neuroscience,
- Clinical Trials,
- Gene Therapy,
- Social Impact,
- Digital Health,
- Medical,
- Information Technology,
- B2B,
- Therapeutics,
- Cellular Therapy,
- Pharmaceuticals
Social media:
Past investments:
- Ona Therapeutics
- eTheRNA immunotherapies
- Indigo Diabetes
- Confo Therapeutics
- Aelin Therapeutics
- Horama
- Minoryx Therapeutics
- ExeVir Bio
- Immunic
- Promethera Biosciences
- OCTIMET Oncology
- ITeos Therapeutics
- IPA (ImmunoPrecise Antibodies)
Investor Profile
Chris Buyse is a Venture Capital, Private Equity Firm based in Flanders, Belgium with a diverse investment portfolio that includes companies such as Ona Therapeutics, eTheRNA immunotherapies, Indigo Diabetes, Confo Therapeutics, Aelin Therapeutics, Horama, Minoryx Therapeutics, ExeVir Bio, Immunic, Promethera Biosciences, OCTIMET Oncology, ITeos Therapeutics, IPA (ImmunoPrecise Antibodies), . Over time, Chris Buyse has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Chris Buyse is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Genetics, Wellness, Tissue Engineering, Healthcare Innovation, Life Science, Portfolio Management, Diabetes, Finance, Biotechnology, Medical Devices, Genomics, Neuroscience, Clinical Trials, Gene Therapy, Social Impact, Digital Health, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals may find it worthwhile to explore potential connections with Chris Buyse, as their portfolio suggests a familiarity and interest in this area.
Understanding Chris Buyse’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
